Meditor Group LTD Has Boosted By $1.03 Million Its Celldex Therapeutics (CLDX) Position; THIN FILM (TFECF) Shorts Raised By 26.93%

THIN FILM (OTCMKTS:TFECF) had an increase of 26.93% in short interest. TFECF’s SI was 9.55M shares in January as released by FINRA. Its up 26.93% from 7.53M shares previously. With 10,200 avg volume, 937 days are for THIN FILM (OTCMKTS:TFECF)’s short sellers to cover TFECF’s short positions. It closed at $0.3 lastly. It is down 0.00% since January 1, 2017 and is . It has underperformed by 16.70% the S&P500.

Meditor Group Ltd increased Celldex Therapeutics (CLDX) stake by 8.84% reported in 2017Q3 SEC filing. Meditor Group Ltd acquired 512,700 shares as Celldex Therapeutics (CLDX)’s stock declined 11.75%. The Meditor Group Ltd holds 6.31M shares with $18.05 million value, up from 5.80M last quarter. Celldex Therapeutics now has $386.20M valuation. The stock decreased 3.07% or $0.09 during the last trading session, reaching $2.84. About 1.16 million shares traded. Celldex Therapeutics, Inc. (NASDAQ:CLDX) has declined 20.62% since January 1, 2017 and is downtrending. It has underperformed by 37.32% the S&P500.

Thin Film Electronics ASA engages in the development, production, and commercialization of printed electronics and smart systems in Norway. The company has market cap of $362.36 million. The firm develops printed memory and systems, which include memory, sensing, display, and wireless communication. It currently has negative earnings. The Company’s products include NFC OpenSense technology that provides smartphone-centric NFC readability before and after product opening; NFC SpeedTap tags, which are wireless tags that enable smartphones to communicate with everyday objects in support of B2B and B2C use cases; and CNECT Partner Portal, a multi-tenant cloud platform that allows brands to connect with clients by enabling engagement through a direct tap or swipe of an near field communication label.

Among 13 analysts covering Celldex Therapeutics (NASDAQ:CLDX), 8 have Buy rating, 0 Sell and 5 Hold. Therefore 62% are positive. Celldex Therapeutics had 24 analyst reports since August 11, 2015 according to SRatingsIntel. The stock of Celldex Therapeutics, Inc. (NASDAQ:CLDX) earned “Hold” rating by Jefferies on Tuesday, August 9. The firm has “Hold” rating given on Thursday, August 31 by Jefferies. The rating was maintained by Cowen & Co on Tuesday, March 8 with “Outperform”. Oppenheimer downgraded the stock to “Perform” rating in Monday, March 7 report. Jefferies maintained Celldex Therapeutics, Inc. (NASDAQ:CLDX) on Monday, June 12 with “Hold” rating. The stock of Celldex Therapeutics, Inc. (NASDAQ:CLDX) has “Buy” rating given on Tuesday, August 11 by TH Capital. Guggenheim downgraded the stock to “Neutral” rating in Monday, March 7 report. As per Tuesday, March 8, the company rating was downgraded by Jefferies. As per Tuesday, August 11, the company rating was maintained by Oppenheimer. The rating was reinitiated by H.C. Wainwright with “Buy” on Tuesday, August 1.

The post Meditor Group LTD Has Boosted By $1.03 Million Its Celldex Therapeutics (CLDX) Position; THIN FILM (TFECF) Shorts Raised By 26.93% appeared first on Stock Market News | HillCountryTimes | Get it Today.

from
https://www.hillcountrytimes.com/2018/01/01/meditor-group-ltd-has-boosted-by-1-03-million-its-celldex-therapeutics-cldx-position-thin-film-tfecf-shorts-raised-by-26-93/